USPH Q2 net income $10.9M ($0.64 EPS); record patient volumes; reaffirms FY23 Adj. EBITDA guidance $75-80M

U S PHYSICAL THERAPY INC /NV

2023-Q2 EPS reported $1.22 revenue$299,994,000

Net income $10.9M ($0.64 GAAP EPS) vs $11.2M ($0.87) in Q2 2022; Operating Results per share $0.76 vs $0.90.
Total net revenue $151.5M (+7.7% YoY); PT operations revenue up 9.4% to $129.3M on record 30.4 visits/clinic/day.
Reaffirmed FY23 Adjusted EBITDA guidance $75-80M; Q2 Adj. EBITDA $21.7M vs $21.3M.
Board declared $0.43/share quarterly dividend payable Sept 8, record Aug 18.
Completed secondary offering of ~1.9M shares for net proceeds $163.7M, used partly to repay debt.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

U S PHYSICAL THERAPY INC /NV updated its three and six months ended June 30, 2023 guidance (reaffirmed).

Period: three and six months ended June 30, 2023
Guidance: reaffirmed
Result: reported results

Exact text from the filing

U.S. Physical Therapy Reports Second Quarter 2023 Results Reports All-Time High Quarterly Patient Volume

View on SEC.gov

31 earnings releases filed in the last 30 days. Browse all earnings releases →

U S PHYSICAL THERAPY INC /NV filing history →

Source: SEC EDGAR

accession 0000885978-23-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.